Literature DB >> 7200024

Effect of an estrogen antagonist (tamoxifen) on the initiation and progression of gamma-irradiation-induced mammary tumors in female Sprague-Dawley rats.

C W Welsch, M Goodrich-Smith, C K Brown, N Miglorie, K H Clifton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7200024     DOI: 10.1016/0014-2964(81)90004-9

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


× No keyword cloud information.
  5 in total

1.  Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model.

Authors:  Norman C Peterson; Matthew D Servinsky; Archie Christian; Zhongsheng Peng; Weiping Qiu; Jill Mann; John Dicello; David L Huso
Journal:  Carcinogenesis       Date:  2005-04-28       Impact factor: 4.944

Review 2.  Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

3.  Multiple susceptibility loci for radiation-induced mammary tumorigenesis in F2[Dahl S x R]-intercross rats.

Authors:  Victoria L Herrera; Lorenz R Ponce; Nelson Ruiz-Opazo
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

Review 4.  Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.

Authors:  Jessica S Helm; Ruthann A Rudel
Journal:  Arch Toxicol       Date:  2020-05-13       Impact factor: 5.153

5.  Development of mammary cancer in γ-irradiated F1 hybrids of susceptible Sprague-Dawley and resistant Copenhagen rats, with copy-number losses that pinpoint potential tumor suppressors.

Authors:  Mayumi Nishimura; Kazuhiro Daino; Maki Fukuda; Ikuya Tanaka; Hitomi Moriyama; Kaye Showler; Yukiko Nishimura; Masaru Takabatake; Toshiaki Kokubo; Atsuko Ishikawa; Kazumasa Inoue; Masahiro Fukushi; Shizuko Kakinuma; Tatsuhiko Imaoka; Yoshiya Shimada
Journal:  PLoS One       Date:  2021-08-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.